Cargando…
Artificial intelligence approach fighting COVID-19 with repurposing drugs
BACKGROUND: The ongoing COVID-19 pandemic has caused more than 193,825 deaths during the past few months. A quick-to-be-identified cure for the disease will be a therapeutic medicine that has prior use experiences in patients in order to resolve the current pandemic situation before it could become...
Autores principales: | Ke, Yi-Yu, Peng, Tzu-Ting, Yeh, Teng-Kuang, Huang, Wen-Zheng, Chang, Shao-En, Wu, Szu-Huei, Hung, Hui-Chen, Hsu, Tsu-An, Lee, Shiow-Ju, Song, Jeng-Shin, Lin, Wen-Hsing, Chiang, Tung-Jung, Lin, Jiunn-Horng, Sytwu, Huey-Kang, Chen, Chiung-Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227517/ https://www.ncbi.nlm.nih.gov/pubmed/32426387 http://dx.doi.org/10.1016/j.bj.2020.05.001 |
Ejemplares similares
-
Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
Statins: a repurposed drug to fight cancer
por: Jiang, Wen, et al.
Publicado: (2021) -
Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
New insights into Blimp-1 in T lymphocytes: a divergent regulator of cell destiny and effector function
por: Fu, Shin-Huei, et al.
Publicado: (2017) -
Development
of Furanopyrimidine-Based Orally Active
Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell
Lung Cancer
por: Li, Mu-Chun, et al.
Publicado: (2023)